nach oben

Journal of Neuro-Oncology

Erschienen in:

06.06.2019 | Clinical Study

LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells

verfasst von: Guoxiong Li, Yingqian Cai, Chuanmei Wang, Min Huang, Jiansheng Chen

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

To investigate the effects of lncRNA GAS5 on the proliferation, migration, invasion and apoptosis of brain glioma cells.

Methods

The expression levels of lncRNA GAS5 and GSTM3 in normal glial cells (HEB) and glioma cells (U251 and U87) were detected by RT-qPCR and western blot, respectively. Glioma cells were transfected with ctrl vector, pcDNA-GAS5, siRNA ctrl (siNC) or GSTM3 siRNA and the effects of lncRNA GAS5 and GSTM3 on the proliferation, migration, invasion and apoptosis of glioma cells were detected by CCK-8 assay, transwell assay and Caspase 3/7 activity assay, respectively.

Results

The expression of lncRNA GAS5 was significantly decreased in glioma cell lines U251 and U87 compared with normal glial cells HEB (p < 0.01). In addition, overexpression of lncRNA GAS5 inhibited the proliferation, migration and invasion of U251 and U87 cells, and promoted cell apoptosis as demonstrated by the increased activity of Caspase 3/7. Furthermore, GSTM3 was predicted as a target gene of lncRNA GAS5 by bioinformatics analysis and its expression was increased in glioma cells compared with the normal cells as indicated by western blotting and RT-qPCR experimental results. Silencing of GSTM3 with GSTM3 siRNA decreased the proliferation, migration and invasion but increased the apoptosis of glioma cell lines U251 and U87, which was similar to that the effect lncRNA GAS5 over-expression.

Conclusion

lncRNA GAS5 can effectively inhibit the proliferation, migration and invasion of glioma cells and promote cell apoptosis through targeting GSTM3 expression.

Jcl A, Talkenberger K, Seifert M, Klink B, Hawkins-Daarud A, Swanson KR, Hatzikirou H, Deutsch A (2017) The biology and mathematical modelling of glioma invasion: a review. J R Soc Interface 14:20170490CrossRef

Stupp R, Hegi ME, Mason WP, Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:434–435CrossRef

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. https://doi.org/10.1056/NEJMoa043330 CrossRef

Wang Z, Guo Q, Wang R, Xu G, Li P, Sun Y, She X, Liu Q, Chen Q, Yu Z, Liu C, Xiong J, Li G, Wu M (2016) The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells. J Hematol Oncol 9:130. https://doi.org/10.1186/s13045-016-0355-1 CrossRefPubMedPubMedCentral

Li B, Huang MZ, Wang XQ, Tao BB, Zhong J, Wang XH, Zhang WC, Li ST (2015) TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion. J Hematol Oncol 8:89. https://doi.org/10.1186/s13045-015-0187-4 CrossRefPubMedPubMedCentral

Xiao C, Wu CH, Hu HZ (2016) LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci 20:2819PubMed

Zhou M, Hou Y, Yang G, Zhang H, Tu G, Du YE, Wen S, Xu L, Tang X, Tang S (2016) LncRNA-Hh strengthen cancer stem cells generation in twist-positive breast cancer via activation of hedgehog signaling pathway. Stem Cells 34:55–66CrossRefPubMed

Han P, Li J, Zhang B, Lv J, Li Y, Gu X, Yu Z, Jia Y, Bai X, Li L (2017) The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol Cancer 16:9CrossRefPubMedPubMedCentral

Peng WX, Koirala P, Mo YY (2017) LncRNA-mediated regulation of cell signaling in cancer. Oncogene 36:5661CrossRefPubMedPubMedCentral

10.

Kanduri C (2016) Long noncoding RNAs: Lessons from genomic imprinting. Biochim Biophys Acta 1859:102–111CrossRefPubMed

11.

Gong C, Popp MW, Maquat LE (2012) Biochemical analysis of long non-coding RNA-containing ribonucleoprotein complexes. Methods 58:88–93CrossRefPubMedPubMedCentral

12.

Fatica A, Bozzoni I (2014) Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 15:7–21CrossRefPubMed

13.

Vassallo I, Zinn P, Lai M, Rajakannu P, Hamou MF, Hegi ME (2016) WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. Oncogene 35:12–21CrossRefPubMed

14.

Cui Y, Zhang F, Zhu C, Geng L, Tian T, Liu H (2017) Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway. Oncotarget 8:17785–17794PubMedPubMedCentral

15.

Sun M, Kraus WL (2015) From Discovery to Function: The Expanding Roles of Long Non-Coding RNAs in Physiology and Disease. Endocr Rev 36:25–64CrossRefPubMed

16.

Wang TH, Chan CW, Fang JY, Shih YM, Liu YW, Wang TCV, Chen CY (2017) 2-O-Methylmagnolol upregulates the long non-coding RNA, GAS5, and enhances apoptosis in skin cancer cells. Cell Death Dis 8:e2638CrossRefPubMedPubMedCentral

17.

Li W, Zhai L, Wang H, Liu C, Zhang J, Chen W, Wei Q (2016) Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer. Oncotarget 7:27778–27786PubMedPubMedCentral

18.

Wang M, Guo C, Wang L, Luo G, Huang C, Li Y, Liu D, Zeng F, Jiang G, Xiao X (2018) Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription. Cell Death Dis 9:238CrossRefPubMedPubMedCentral

19.

Renganathan A, Kresoja-Rakic J, Echeverry N, Ziltener G, Vrugt B, Opitz I, Stahel RA, Felley-Bosco E (2014) GAS5 long non-coding RNA in malignant pleural mesothelioma. Mol Cancer 13(1):119CrossRefPubMedPubMedCentral

20.

Guo C, W-q Song, Sun P, Jin L, H-y Dai (2015) LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells. J Biomed Sci 22:100CrossRefPubMedPubMedCentral

21.

Wen Q, Liu Y, Lyu H, Xu X, Wu Q, Liu N, Yin Q, Li J, Sheng X (2017) Long noncoding RNA GAS5, which acts as a tumor suppressor via microRNA 21, regulates cisplatin resistance expression in cervical cancer. Int J Gynecol Cancer 27:1096CrossRefPubMedPubMedCentral

22.

Pectasides D, Kamposioras K, Papaxoinis G, Pectasides E (2008) Chemotherapy for recurrent cervical cancer. Cancer Treat Rev 34:603–613CrossRefPubMed

23.

Huang J, Tan PH, Thiyagarajan J, Bay BH (2003) Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Mod Pathol 16:558CrossRefPubMed

24.

Dixon DP, Edwards R (2010) Glutathione Transferases. Annu Rev Pharmacol Toxicol 8:e0131

25.

Meding S, Balluff B, Elsner M, Schöne C, Rauser S, Nitsche U, Maak M, Schäfer A, Hauck SM, Ueffing M (2012) Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer. J Pathol 228:459–470CrossRefPubMed

26.

Mitra AP, Pagliarulo V, Yang D, Waldman FM, Datar RH, Skinner DG, Groshen S, Cote RJ (2009) Generation of a concise gene panel for outcome prediction in urinary bladder cancer. J Clin Oncol 27:3929–3937CrossRefPubMedPubMedCentral

27.

Ye Z, Song H, Higgins JPT, Pharoah P, Danesh J (2006) Five glutathione S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. Plos Med 3:e91CrossRefPubMedPubMedCentral

28.

Medeiros R, Vasconcelos A, Costa S, Pinto D, Ferreira P, Lobo F, Morais A, Oliveira J, Lopes C (2004) Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate 58:414–420CrossRefPubMed

29.

Checarojas A, Delgadillosilva LF, Velascoherrera M, Andradedomínguez A, Gil J, Santillán O, Lozano L, Toledoleyva A, Ramíreztorres A, Talamasrohana P (2018) GSTM3 and GSTP1: novel players driving tumor progression in cervical cancer. Oncotarget 9:21696–21714

30.

Louie SM, Grossman EA, Crawford LA, Ding L, Camarda R, Huffman TR, Miyamoto DK, Goga A, Weerapana E, Nomura DK (2016) GSTP1 is a driver of triple-negative breast cancer cell metabolism and pathogenicity. Cell Chem Biol 23:567–578CrossRefPubMedPubMedCentral

31.

Xu Y, Wang J, Dong W (2014) GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis. PLoS ONE 9:e83851CrossRefPubMedPubMedCentral

32.

Kumar B, Hovland AR, Prasad JE, Clarkson E, Cole WC, Nahreini P, Freed CR, Prasad KN (2001) Establishment of human embryonic brain cell lines. Vitro Cell Dev Biol Animal 37:259–262CrossRef

33.

Nahreini P, Andreatta C, Kumar B, Hanson A, Edwards-Prasad J, Freed CR, Prasad KN (2003) Distinct patterns of gene expression induced by viral oncogenes in human embryonic brain cells. Cell Mol Neurobiol 23:27–42CrossRefPubMed

34.

Sith S, Reardon DA, Annick D, Quinn JA, Vredenburgh JJ, Rich JN (2010) Molecularly targeted therapy for malignant glioma. Cancer 110:13–24

35.

Liu Y, Zhao J, Zhang W, Gan J, Hu C, Huang G, Zhang Y (2015) lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Sci Rep 5:10159CrossRefPubMedPubMedCentral

36.

Liang W, Lv T, Shi X, Liu H, Zhu Q, Zeng J, Yang W, Yin J, Song Y (2016) Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer. Medicine 95:e4608CrossRefPubMedPubMedCentral

37.

Huo JF, Chen XB (2018) Long noncoding RNA growth arrest-specific 5 facilitates glioma cell sensitivity to cisplatin by suppressing excessive autophagy in an mTOR-dependent manner. J Cell Biochem 120:6127–6136CrossRefPubMed

38.

Liu Q, Yu W, Zhu S, Cheng K, Xu H, Lv Y, Long X, Ma L, Huang J, Sun S (2019) Long noncoding RNA GAS5 regulates the proliferation, migration, and invasion of glioma cells by negatively regulating miR-18a-5p. J Cell Physiol 234:757–768CrossRef

39.

Zhao X, Liu Y, Zheng J, Liu X, Chen J, Liu L, Wang P, Xue Y (2017) GAS5 suppresses malignancy of human glioma stem cells via a miR-196a-5p/FOXO1 feedback loop. Biochem Biophys Acta 1864:1605–1617CrossRef

40.

Checa-Rojas A, Delgadillo-Silva LF, del Castillo Velasco-Herrera M, Andrade-Domínguez A, Gil J, Santillán O, Lozano L, Toledo-Leyva A, Ramírez-Torres A, Talamas-Rohana P (2018) GSTM3 and GSTP1: novel players driving tumor progression in cervical cancer. Oncotarget 9:21696–21714CrossRefPubMedPubMedCentral

41.

Wang Y, Yang ZY, Chen YH, Li F, Shen H, Yu Y, Huang HY, Shen ZY (2018) A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR-556 binding. J Cell Mol Med 22:3005–3015CrossRefPubMedPubMedCentral

42.

Zhang Y, Hughes KS (2009) Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma. Am J Epidemiol 170:1222–1230CrossRefPubMedPubMedCentral

43.

Gabriel E, Yong-Shu Z, Qing-Lin L, Ji-Xiang X, Yuan Y, Qun Z (2014) Long non-coding RNAs in stem cells and cancer. World J Clin Oncol 5:134–141CrossRef

44.

Man-Tang Q, Jing-Wen H, Rong Y, Lin X (2013) Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol J Int Soc Oncodev Biol Med 34:613–620CrossRef

45.

Yang W, Hong L, Xu X, Wang Q, Huang J, Jiang L (2017) LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205. Tumour Biol 39:1010428317711315PubMed

46.

Guo C, Song WQ, Sun P, Jin L, Dai HY (2015) LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells. J Biomed Sci 22:100CrossRefPubMedPubMedCentral

47.

Geng X, Xu X, Zhao Y, Hu J, Xu J, Jia P, Ding X, Teng J (2018) The effect of long noncoding RNA GAS5 on apoptosis in renal ischemia/reperfusion injury. Nephrology 24:405–413CrossRef

48.

Zhao X, Wang P, Liu J, Zheng J, Liu Y, Chen J, Xue Y (2015) Gas5 exerts tumor-suppressive functions in human glioma cells by targeting miR-222. Mol Ther 23:1899–1911CrossRefPubMedPubMedCentral

Titel: LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells
verfasst von: Guoxiong Li
Yingqian Cai
Chuanmei Wang
Min Huang
Jiansheng Chen
Publikationsdatum: 06.06.2019
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2019
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-019-03185-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis

Comparative analysis of intracranial meningiomas in patients younger than 40 years

Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences

Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres

Applicability and limitations of a recently-proposed prognostic grading metric, initial brain metastasis velocity, for brain metastasis patients undergoing stereotactic radiosurgery